Nomogram to predict duration of clinical benefit from nivolumab in platinum resistant, recurrent/metastatic head and neck squamous cell carcinoma
Feeney, L. Rack, Samuel Mistry, Hitesh Bola, Becky McPartlin, Andrew J Sykes, Andrew J Metcalf, Robert
Feeney, L.
Rack, Samuel
Mistry, Hitesh
Bola, Becky
McPartlin, Andrew J
Sykes, Andrew J
Metcalf, Robert
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Feeney L, Rack S, Mistry H, Bola B, McPartlin A, Sykes A, et al. Nomogram to predict duration of clinical benefit from nivolumab in platinum resistant, recurrent/metastatic head and neck squamous cell carcinoma. Journal of Clinical Oncology. 2022 Jun;40(16):E18016-E. PubMed PMID: WOS:000863680303594.